This is because H/K-HELP-pulsed DCVAC is expected to be a good cancer treatment for inducing stronger Th1-dependent antitumor immunity against WT-1 and survivin common cancer antigens in addition to neoantigens released by radiotherapy-induced ICD. This evidence concerns the gene BIRC5 and cancer.